BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26248957)

  • 1. Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test.
    Pane M; Fanelli L; Mazzone ES; Olivieri G; D'Amico A; Messina S; Scutifero M; Battini R; Petillo R; Frosini S; Sivo S; Vita GL; Bruno C; Mongini T; Pegoraro E; De Sanctis R; Gardani A; Berardinelli A; Lanzillotta V; Carlesi A; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Bianco F; Bonfiglio S; Rolle E; Palermo C; D'Angelo G; Pini A; Iotti E; Gorni K; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
    Neuromuscul Disord; 2015 Oct; 25(10):749-53. PubMed ID: 26248957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.
    Pane M; Coratti G; Brogna C; Mazzone ES; Mayhew A; Fanelli L; Messina S; D'Amico A; Catteruccia M; Scutifero M; Frosini S; Lanzillotta V; Colia G; Cavallaro F; Rolle E; De Sanctis R; Forcina N; Petillo R; Barp A; Gardani A; Pini A; Monaco G; D'Angelo MG; Zanin R; Vita GL; Bruno C; Mongini T; Ricci F; Pegoraro E; Bello L; Berardinelli A; Battini R; Sansone V; Albamonte E; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
    PLoS One; 2018; 13(6):e0199223. PubMed ID: 29924848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study.
    Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F
    Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Performance of the Upper Limb scores correlate with pulmonary function test measures and Egen Klassifikation scores in Duchenne muscular dystrophy.
    Lee HN; Sawnani H; Horn PS; Rybalsky I; Relucio L; Wong BL
    Neuromuscul Disord; 2016; 26(4-5):264-71. PubMed ID: 27056113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Annoussamy M; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Mayer M; Maincent K; Desguerre I; Thémar-Noël C; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(2):e0113999. PubMed ID: 25643053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.
    McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H;
    Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study.
    Coratti G; Pane M; Brogna C; D'Amico A; Pegoraro E; Bello L; Sansone VA; Albamonte E; Ferraroli E; Mazzone ES; Fanelli L; Messina S; Sframeli M; Catteruccia M; Cicala G; Capasso A; Ricci M; Frosini S; De Luca G; Rolle E; De Sanctis R; Forcina N; Norcia G; Passamano L; Scutifero M; Gardani A; Pini A; Monaco G; D'Angelo MG; Leone D; Zanin R; Vita GL; Panicucci C; Bruno C; Mongini T; Ricci F; Berardinelli A; Battini R; Masson R; Baranello G; Dosi C; Bertini E; Nigro V; Politano L; Mercuri E
    Neuromuscul Disord; 2024 Jan; 34():75-82. PubMed ID: 38157655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys.
    Pane M; Mazzone ES; Sivo S; Fanelli L; De Sanctis R; D'Amico A; Messina S; Battini R; Bianco F; Scutifero M; Petillo R; Frosini S; Scalise R; Vita GL; Bruno C; Pedemonte M; Mongini T; Pegoraro E; Brustia F; Gardani A; Berardinelli A; Lanzillotta V; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Busato F; Bonfiglio S; Rolle E; Colia G; Bonetti A; Palermo C; Graziano A; D'Angelo G; Pini A; Corlatti A; Gorni K; Baranello G; Antonaci L; Bertini E; Politano L; Mercuri E
    PLoS Curr; 2014 Oct; 6():. PubMed ID: 25642376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy.
    Pane M; Mazzone ES; Fanelli L; De Sanctis R; Bianco F; Sivo S; D'Amico A; Messina S; Battini R; Scutifero M; Petillo R; Frosini S; Scalise R; Vita G; Bruno C; Pedemonte M; Mongini T; Pegoraro E; Brustia F; Gardani A; Berardinelli A; Lanzillotta V; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Bonfiglio S; Rolle E; Colia G; Catteruccia M; Palermo C; D'Angelo G; Pini A; Iotti E; Gorni K; Baranello G; Morandi L; Bertini E; Politano L; Sormani M; Mercuri E
    Neuromuscul Disord; 2014 Mar; 24(3):201-6. PubMed ID: 24440357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
    Mazzone ES; Pane M; Sormani MP; Scalise R; Berardinelli A; Messina S; Torrente Y; D'Amico A; Doglio L; Viggiano E; D'Ambrosio P; Cavallaro F; Frosini S; Bello L; Bonfiglio S; De Sanctis R; Rolle E; Bianco F; Magri F; Rossi F; Vasco G; Vita G; Motta MC; Donati MA; Sacchini M; Mongini T; Pini A; Battini R; Pegoraro E; Previtali S; Napolitano S; Bruno C; Politano L; Comi GP; Bertini E; Mercuri E
    PLoS One; 2013; 8(1):e52512. PubMed ID: 23326337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment.
    Merlini L; Cecconi I; Parmeggiani A; Cordelli DM; Dormi A
    Acta Myol; 2020 Dec; 39(4):200-206. PubMed ID: 33458575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy.
    Buyse GM; Goemans N; van den Hauwe M; Meier T
    Pediatr Pulmonol; 2013 Sep; 48(9):912-20. PubMed ID: 23129412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth, bone health & ambulatory status of boys with DMD treated with daily vs. intermittent oral glucocorticoid regimen.
    Crabtree NJ; Adams JE; Padidela R; Shaw NJ; Högler W; Roper H; Hughes I; Daniel A; Mughal MZ
    Bone; 2018 Nov; 116():181-186. PubMed ID: 30055340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment.
    Le Moing AG; Seferian AM; Moraux A; Annoussamy M; Dorveaux E; Gasnier E; Hogrel JY; Voit T; Vissière D; Servais L
    PLoS One; 2016; 11(6):e0156696. PubMed ID: 27271157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manual ability and upper limb performance in nonambulatory stage of Duchenne muscular dystrophy.
    Demir G; Bulut N; Yılmaz Ö; Karaduman A; Alemdaroğlu-Gürbüz İ
    Arch Pediatr; 2020 Aug; 27(6):304-309. PubMed ID: 32718814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional levels and MRI patterns of muscle involvement in upper limbs in Duchenne muscular dystrophy.
    Brogna C; Cristiano L; Tartaglione T; Verdolotti T; Fanelli L; Ficociello L; Tasca G; Battini R; Coratti G; Forcina N; De Santis R; Norcia G; Carnicella S; Colosimo C; Carlier P; Pane M; Mercuri E
    PLoS One; 2018; 13(6):e0199222. PubMed ID: 29924868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling upper extremity performance in Duchenne muscular dystrophy: A biophysical model.
    Janssen MMHP; Harlaar J; Koopman B; de Groot IJM
    Neuromuscul Disord; 2019 May; 29(5):368-375. PubMed ID: 31029531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids.
    McDonald CM; Gordish-Dressman H; Henricson EK; Duong T; Joyce NC; Jhawar S; Leinonen M; Hsu F; Connolly AM; Cnaan A; Abresch RT;
    Neuromuscul Disord; 2018 Nov; 28(11):897-909. PubMed ID: 30336970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reachable workspace and performance of upper limb (PUL) in duchenne muscular dystrophy.
    Han JJ; de Bie E; Nicorici A; Abresch RT; Anthonisen C; Bajcsy R; Kurillo G; Mcdonald CM
    Muscle Nerve; 2016 Apr; 53(4):545-54. PubMed ID: 26342193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.